Corticosteroids for idiopathic pulmonary fibrosis
Author:
Affiliation:
1. Policlinico di Modena, Universita di Modena e Reggio Emilia; Divisione di Pneumologia; Via del Pozzo, 71 Modena Italy 41100
2. Repatriation General Hospital; c/o Division of Medicine; Daws Road Daw Park South Australia Australia 5041
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD002880/fullpdf
Reference23 articles.
1. Response to steroid therapy in patients of idiopathic pulmonary fibrosis: a retrospective analysis;Behera;The Indian Journal of Chest Diseases & Allied Sciences,1998
2. Colchicine versus prednisone as treatment of usual interstitial pneumonia;Douglas;Mayo Clinic Proceedings,1997
3. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study;Douglas;American Journal of Respiratory and Critical Care Medicine,1998
4. Idiopathic pulmonary fibrosis. Impact of oxygen and colchicine, prednisone, or no therapy on survival;Douglas;American Journal of Respiratory and Critical Care Medicine,2000
5. Idiopathic Pulmonary Fibrosis. Predicting response to therapy and survival;Gay;American Journal of Respiratory and Critical Care Medicine,1998
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. NLRP3 inflammasome activation contributes to the development of the pro-fibrotic phenotype of lung fibroblasts;Biochemical Pharmacology;2024-11
2. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27
3. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways;Stem Cell Research & Therapy;2024-06-18
4. Triamcinolone acetonide alleviates benign biliary stricture by ameliorating biliary fibrosis and inflammation;BMB Reports;2024-03-11
5. Cellular therapies for idiopathic pulmonary fibrosis: current progress and future prospects;American Journal of Stem Cells;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3